BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12663525)

  • 1. Combined oral benzo[a]pyrene and inhalatory ozone exposure have no effect on lung tumor development in DNA repair-deficient Xpa mice.
    Hoogervorst EM; de Vries A; Beems RB; van Oostrom CT; Wester PW; Vos JG; Bruins W; Roodbergen M; Cassee FR; Vijg J; van Schooten FJ; van Steeg H
    Carcinogenesis; 2003 Mar; 24(3):613-9. PubMed ID: 12663525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: correlation with tumour development.
    de Vries A; Dollé ME; Broekhof JL; Muller JJ; Kroese ED; van Kreijl CF; Capel PJ; Vijg J; van Steeg H
    Carcinogenesis; 1997 Dec; 18(12):2327-32. PubMed ID: 9450477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
    van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
    Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice deficient in the nucleotide excision repair gene XPA have elevated sensitivity to benzo[a]pyrene induction of lung tumors.
    Ide F; Iida N; Nakatsuru Y; Oda H; Tanaka K; Ishikawa T
    Carcinogenesis; 2000 Jun; 21(6):1263-5. PubMed ID: 10837020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzo[a]pyrene (BP) DNA adduct formation in DNA repair-deficient p53 haploinsufficient [Xpa(-/-)p53(+/-)] and wild-type mice fed BP and BP plus chlorophyllin for 28 days.
    John K; Pratt MM; Beland FA; Churchwell MI; McMullen G; Olivero OA; Pogribny IP; Poirier MC
    Carcinogenesis; 2012 Nov; 33(11):2236-41. PubMed ID: 22828138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of cancer-related pathways in primary hepatocytes derived from DNA repair-deficient Xpa-/-p53+/- mice upon exposure to benzo[a]pyrene.
    van Kesteren PC; Zwart PE; Pennings JL; Gottschalk WH; Kleinjans JC; van Delft JH; van Steeg H; Luijten M
    Toxicol Sci; 2011 Sep; 123(1):123-32. PubMed ID: 21715664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.
    Kucab JE; van Steeg H; Luijten M; Schmeiser HH; White PA; Phillips DH; Arlt VM
    Mutat Res; 2015 Mar; 773():48-62. PubMed ID: 25847421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated frequencies of benzo(a)pyrene-induced Hprt mutations in internal tissue of XPA-deficient mice.
    Bol SA; van Steeg H; Jansen JG; Van Oostrom C; de Vries A; de Groot AJ; Tates AD; Vrieling H; van Zeeland AA; Mullenders LH
    Cancer Res; 1998 Jul; 58(13):2850-6. PubMed ID: 9661901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delay of DNA-adduct repair and severe toxicity in xeroderma pigmentosum group A gene (XPA) deficient mice treated with 2-amino-1-methyl-6-phenyl-imidazo [4,5-b] pyridine (PhIP).
    Imaida K; Ogawa K; Takahashi S; Ito T; Yamaguchi T; Totsuka Y; Wakabayashi K; Tanaka K; Ito N; Shirai T
    Cancer Lett; 2000 Mar; 150(1):63-9. PubMed ID: 10755388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice.
    Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; Gielis S; Vermeulen JP; Wester PW; Vos JG; de Vries A; van Steeg H
    Cancer Res; 2004 Aug; 64(15):5118-26. PubMed ID: 15289314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice.
    de Vries A; van Oostrom CT; Dortant PM; Beems RB; van Kreijl CF; Capel PJ; van Steeg H
    Mol Carcinog; 1997 May; 19(1):46-53. PubMed ID: 9180928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice.
    van Steeg H; Mullenders LH; Vijg J
    Mutat Res; 2000 May; 450(1-2):167-80. PubMed ID: 10838141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XP-A cells complemented with Arg228Gln and Val234Leu polymorphic XPA alleles repair BPDE-induced DNA damage better than cells complemented with the wild type allele.
    Porter PC; Mellon I; States JC
    DNA Repair (Amst); 2005 Mar; 4(3):341-9. PubMed ID: 15661657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzo[a]pyrene-induced transcriptomic responses in primary hepatocytes and in vivo liver: toxicokinetics is essential for in vivo-in vitro comparisons.
    van Kesteren PC; Zwart PE; Schaap MM; Pronk TE; van Herwijnen MH; Kleinjans JC; Bokkers BG; Godschalk RW; Zeilmaker MJ; van Steeg H; Luijten M
    Arch Toxicol; 2013 Mar; 87(3):505-15. PubMed ID: 23052197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA adduct kinetics in reproductive tissues of DNA repair proficient and deficient male mice after oral exposure to benzo(a)pyrene.
    Verhofstad N; van Oostrom CT; van Benthem J; van Schooten FJ; van Steeg H; Godschalk RW
    Environ Mol Mutagen; 2010 Mar; 51(2):123-9. PubMed ID: 19634154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers.
    Pavanello S; Pulliero A; Siwinska E; Mielzynska D; Clonfero E
    Carcinogenesis; 2005 Jan; 26(1):169-75. PubMed ID: 15471894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
    van Steeg H; de Vries A; van Oostrom CTh ; van Benthem J; Beems RB; van Kreijl CF
    Toxicol Pathol; 2001; 29 Suppl():109-16. PubMed ID: 11695546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal toxicity and carcinogenic potential of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in DNA repair deficient XPA-/- mice.
    Klein JC; Beems RB; Zwart PE; Hamzink M; Zomer G; van Steeg H; van Kreijl CF
    Carcinogenesis; 2001 Apr; 22(4):619-26. PubMed ID: 11285198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential ultraviolet-B-induced immunomodulation in XPA, XPC, and CSB DNA repair-deficient mice.
    Boonstra A; van Oudenaren A; Baert M; van Steeg H; Leenen PJ; van der Horst GT; Hoeijmakers JH; Savelkoul HF; Garssen J
    J Invest Dermatol; 2001 Jul; 117(1):141-6. PubMed ID: 11442761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 and lacZ mutagenesis induced by 3-nitrobenzanthrone in Xpa-deficient human TP53 knock-in mouse embryo fibroblasts.
    Kucab JE; Zwart EP; van Steeg H; Luijten M; Schmeiser HH; Phillips DH; Arlt VM
    DNA Repair (Amst); 2016 Mar; 39():21-33. PubMed ID: 26723900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.